$4.37
0[0.00%]
At close: Apr 19
$4.37
0[0.00%]
After Hours: 5:48PM EDT
Cardiff Oncology
(NASDAQ:CRDF)Latest News for Cardiff Oncology Stock (NASDAQ:CRDF)
Cardiff Oncology Stock (NASDAQ: CRDF)
Categories: All
Monday, April 08, 2024
Wednesday, March 13, 2024
Wednesday, March 06, 2024
Monday, March 04, 2024
Friday, March 01, 2024
- Crude Oil Rises Over 2%; Fisker Shares PlummetAvi Kapoor - Mar 1, 2024, 2:32PM
- Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Mar 1, 2024, 1:19PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Mar 1, 2024, 12:34PM
- Nasdaq Surges 100 Points; ISM Manufacturing PMI Falls In FebruaryAvi Kapoor - Mar 1, 2024, 12:16PM
- Small Cap-Cardiff Oncology Outlines Data From Discontinued Colorectal Cancer Trial, Stock SoarsVandana Singh - Mar 1, 2024, 11:38AM
- Piper Sandler Maintains Overweight on Cardiff Oncology, Raises Price Target to $7Benzinga Newsdesk - Mar 1, 2024, 10:02AM
- Cardiff Oncology shares are trading higher after the company reported better-than-expected Q4 financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.Benzinga Newsdesk - Mar 1, 2024, 8:49AM
- Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 1, 2024, 8:31AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Mar 1, 2024, 8:09AM
Thursday, February 29, 2024
- Cardiff Oncology shares are trading higher after the company reported better-than-expected Q4 financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.Benzinga Newsdesk - Feb 29, 2024, 5:03PM
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Feb 29, 2024, 4:31PM
- Cardiff Oncology Q4 2023 GAAP EPS $(0.210) Beats $(0.280) Estimate, Sales $156.000K Beat $37.500K EstimateBenzinga Newsdesk - Feb 29, 2024, 4:20PM
- Recap: Cardiff Oncology Q4 EarningsBenzinga Insights - Feb 29, 2024, 4:20PM
- Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)Benzinga Newsdesk - Feb 29, 2024, 4:16PM
- Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial, Says Data 'repeats the efficacy findings of onvansertib in bev naïve patients seen in the company's earlier Phase 1b/2 KRAS-mutated mCRC trial.'Benzinga Newsdesk - Feb 29, 2024, 4:16PM
- Earnings Scheduled For February 29, 2024Benzinga Insights - Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Wednesday, February 14, 2024
Wednesday, January 17, 2024
Wednesday, December 20, 2023
Thursday, November 02, 2023
Wednesday, November 01, 2023
Wednesday, September 27, 2023
- Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Sep 27, 2023, 12:48PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Sep 27, 2023, 9:06AM
- Market-Moving News for September 26thBenzinga Newsdesk - Sep 27, 2023, 8:40AM
- Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving PremarketLisa Levin - Sep 27, 2023, 8:15AM
Tuesday, September 26, 2023
- Why Cardiff Oncology Stock Is Rising After HoursRyan Gustafson - Sep 26, 2023, 5:28PM
- Cardiff Oncology shares are trading higher after the company announced clinical data in pancreatic cancer and small cell lung cancer, including single-agent activity from onvansertib monotherapy.Benzinga Newsdesk - Sep 26, 2023, 4:35PM
- Cardiff Oncology Announces Clinical Data In Pancreatic Cancer And Small Cell Lung Cancer, Including Single-Agent Activity From Onvansertib MonotherapyHappy Mohamed - Sep 26, 2023, 4:09PM
Friday, August 11, 2023
Wednesday, August 09, 2023
Tuesday, August 08, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Aug 8, 2023, 1:31PM
- Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Aug 8, 2023, 1:13PM
- Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving PremarketLisa Levin - Aug 8, 2023, 8:20AM
- HC Wainwright & Co. Maintains Buy on Cardiff Oncology, Lowers Price Target to $13Benzinga Newsdesk - Aug 8, 2023, 7:23AM